RecruitingPhase 4NCT05805436

Preop Laxatives in Robotic Urologic Surgery

Studying Papillary renal cell carcinoma

Last synced from ClinicalTrials.gov May 16, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Chad R. Tracy
Intervention: Polyethylene Glycol 3350(drug)
Enrollment: 240 target
Eligibility: 30-100 years · All sexes
Timeline: 2023 – 2026

Study locations (1)

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05805436 on ClinicalTrials.gov

Other trials for Papillary renal cell carcinoma

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT07586332
INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Trakya University
RECRUITINGNCT06956144
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
The First Affiliated Hospital of Xiamen University
RECRUITINGNCT06532422
Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy
GCS Ramsay Santé pour l'Enseignement et la Recherche
RECRUITINGNANCT06542484
The Real-world Treatment Satisfaction by Gefapixiant in RCC
Nagoya City University
RECRUITINGPHASE3NCT06467097
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Samsung Medical Center
ACTIVE NOT RECRUITINGPHASE1NCT05704985
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
ACTIVE NOT RECRUITINGPHASE2NCT05411081
Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
National Cancer Institute (NCI)
RECRUITINGPHASE3NCT03669783
Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)
Assistance Publique Hopitaux De Marseille

See all trials for Papillary renal cell carcinoma →

← Back to all trials